← All patents

US10136894B2

Nerve treatment methods

University of Texas System

Abstract

The present disclosure is directed to the use of fusogenic compounds such as polyethylene glycol (PEG) in combination with antioxidants, calcium-containing and calcium-free solutions for treating damaged nerves, such as for reconnecting severed nerves.

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
George D. Bittner
Priority date
February 25, 2011
Filing date
May 17, 2017
Grant date
November 27, 2018
Publication date
November 27, 2018
Language
en
Metadata fetched
August 29, 2026 00:25